Stem Cell Transplant and Cellular Therapies Symposium 2026: Managing Capacity in the Era of Advanced Therapies

  • Continuing Education
image of cells under a microscope.

Registration Deadline: October 16

Enhance your ability to manage capacity effectively by gaining essential knowledge and strategies to streamline care and improve outcomes for patients undergoing stem cell transplants or CAR T-cell therapies.

  • Live Online or In Person

This course is taught in person and online in real time.

Dana-Farber Yawkey Building Room 306/307 | 450 Brookline Avenue, Boston, MA

This is the standard price, for a full list of profession pricing see below. 
View All

Continuing Education

Earn up to:
7.50 AMA PRA Category 1 Credit(s) ™
View All

One Day

Please view the Schedule for a full description of the program.

On This Page

Overview

This program addresses the critical need to enhance capacity management among healthcare professionals involved in the care of patients receiving stem cell transplants or CAR T-cell therapies. As these advanced cell therapies become increasingly accessible, healthcare providers face challenges in balancing growing patient volumes with limited resources and infrastructure. This course aims to equip clinicians and community partners with the knowledge and strategies needed to optimize capacity, streamline care delivery, and improve outcomes for patients undergoing these complex treatments.

Learning Objectives

  • Expand community access through shared-care education, referral partnerships, and site-of-care alignment.
  • Prepare for evolving cell/gene therapy and myeloma care, including ID management and emerging pipeline innovations.
  • Explore NMDP/HLA Today donor and allo-referral processes, including APP utilization and family donor criteria.
  • Optimize lymphoma referral pathways and current-state treatment coordination.
  • Implement telemedicine best practices and adapt to evolving Medicare rules.

Developed and Offered By:

  • Dana-Farber Cancer Institute Logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Dana-Farber Cancer Institute.

Who Should Participate

Nurses, Nurse Practitioners, Specialty Physicians, Hematology Oncologists, Physician Assistants, Primary Care Physicians, and Social Workers

Faculty

Harvard Medical School Continuing Education offers faculty who are international experts and leading educators in their fields. As a student in this course, you’ll have access to outstanding course directors and faculty.

 

Course Directors

Greg Bourdeau

Jose Cancelas, MD, PhD
Director of Connell and O'Reilly Families Cell Manipulation Core Facility 

Colleen Gerrity, MSN, RN, CPHON
Nurse Director of Pediatric Oncology, Dana-Farber Cancer Institute 

Caron Jacobson, MD
Medical Director, Immune Effector Cell Therapy Program

Amy Joyce, NP

Amar Kelkar, MD

Leslie Lehmann, MPH
Clinical Director, Pediatric Stem Cell Transplant Center & Medical Directory for International Hematology Oncology / Bone Marrow Transplant at Boston Children's Hospital

John Manis, MD

Kidest Mequanent, MHA
Network Manager, Cell Therapies 

Clifton Mo, MD
Director of Autologous Stem Cell Transplantation for Multiple Myeloma

Omar Nadeem, MD

Sarah Nikiforow, MD, PhD
Technical Director, Immune Effector Cell Therapy Program

Michelle Noiles, PA-C

Julie Porter, MS
Vice President, Cellular Therapies Operations

David Qualls, MD

Linda Ramsdell, MSN, FNP-BC, OCN
Assistant Program Director of Immune Effector Cellular Therapy

John Reagan, MD
Hematology Oncologist

Ankita Shah, NP

Amy Sherman, MD
Instructor, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital and Dana-Farber Cancer Institute 
Research Associate, Precision Vaccines Program, Boston Children’s Hospital

Eric Smith

Mark Trusheim, MS
Founder and President of Co-Bio Consulting, LLC & Strategic Director of NEWDIGS at the MIT Center for Biomedical Innovation

Complete Your Registration

Started a registration? Log in to enroll today.

Log in to Access.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Registration Details

Dana-Farber Cancer Institute and Mass General Brigham staff are eligible for a registration discount. Contact  kidest_mequanent@dfci.harvard.edu

Dana-Farber Cancer Institute and Mass General Brigham staff are eligible for a registration discount. Contact  kidest_mequanent@dfci.harvard.edu

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

The Harvard Medical School designates this Hybrid for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Harvard Medical School designates this Harvard Medical School designates this live activity for a maximum of 6.00 ANCC contact hours.

The National Commission on Certification of Physician Assistants (NCCPA) states that  6.00 AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Provide Patient-Centered Care
  • Work in Interdisciplinary Teams
  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-Based Learning and Improvement

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics

Program Specialties